These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5078669)

  • 21. Smallpox vaccination and patients with human immunodeficiency virus infection or acquired immunodeficiency syndrome.
    Bartlett JG
    Clin Infect Dis; 2003 Feb; 36(4):468-71. PubMed ID: 12567305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progressive vaccinia as an adverse event following exposure to vaccinia virus: case definition and guidelines of data collection, analysis, and presentation of immunization safety data.
    Nell P; Kohl KS; Graham PL; LaRussa PS; Marcy SM; Fulginiti VA; Martin B; McMahon A; Norton SA; Trolin I;
    Vaccine; 2007 Aug; 25(31):5735-44. PubMed ID: 17540484
    [No Abstract]   [Full Text] [Related]  

  • 23. Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination.
    Kennedy JS; Frey SE; Yan L; Rothman AL; Cruz J; Newman FK; Orphin L; Belshe RB; Ennis FA
    J Infect Dis; 2004 Oct; 190(7):1286-94. PubMed ID: 15346340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistence of vaccinia at the site of smallpox vaccination.
    Cummings JF; Polhemus ME; Hawkes C; Klote M; Ludwig GV; Wortmann G
    Clin Infect Dis; 2008 Jan; 46(1):101-2. PubMed ID: 18171221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
    Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
    Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of vaccinia viremia after smallpox vaccination.
    Cummings JF; Polhemus ME; Hawkes C; Klote M; Ludwig GV; Wortmann G
    Clin Infect Dis; 2004 Feb; 38(3):456-8. PubMed ID: 14727224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34(+)-derived dendritic cell vaccination: a phase I trial in metastatic melanoma.
    Di Nicola M; Carlo-Stella C; Mortarini R; Baldassari P; Guidetti A; Gallino GF; Del Vecchio M; Ravagnani F; Magni M; Chaplin P; Cascinelli N; Parmiani G; Gianni AM; Anichini A
    Clin Cancer Res; 2004 Aug; 10(16):5381-90. PubMed ID: 15328176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatal vaccinia associated with cortisone therapy.
    HANSENPRUSS OC; OLANSKY S; SMITH JG
    J Am Med Assoc; 1956 Oct; 162(9):887-8. PubMed ID: 13366679
    [No Abstract]   [Full Text] [Related]  

  • 29. Risk of vaccinia transfer to the hands of vaccinated persons after smallpox immunization.
    Talbot TR; Ziel E; Doersam JK; LaFleur B; Tollefson S; Edwards KM
    Clin Infect Dis; 2004 Feb; 38(4):536-41. PubMed ID: 14765347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The persistence of humoral and cellular immunities more than three decades after smallpox vaccination.
    Kim SH; Yeo SG; Park KH; Bang JW; Kim HB; Kim NJ; Jee Y; Cho H; Oh MD; Choe KW
    Clin Microbiol Infect; 2007 Jan; 13(1):91-3. PubMed ID: 17184294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory-acquired vaccinia infection.
    Wlodaver CG; Palumbo GJ; Waner JL
    J Clin Virol; 2004 Mar; 29(3):167-70. PubMed ID: 14962785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smallpox vaccination of eczema patients with a strain of attenuated live vaccinia (CVI-78).
    Kempe CH; Fulginiti V; Minamitani M; Shinefield H
    Pediatrics; 1968 Dec; 42(6):980-5. PubMed ID: 5726388
    [No Abstract]   [Full Text] [Related]  

  • 33. [Late dermal complication of smallpox vaccination].
    Farkas E; Nyerges G; Kiss S
    Orv Hetil; 1969 Jul; 110(29):1690-2. PubMed ID: 5803909
    [No Abstract]   [Full Text] [Related]  

  • 34. Smallpox conquered, vaccinia directed against hepatitis B.
    Hosp Pract (Off Ed); 1983 Aug; 18(8):35-6, 38. PubMed ID: 6409790
    [No Abstract]   [Full Text] [Related]  

  • 35. Vaccinia reactive antibodies in a south Indian population.
    Kannangai R; Finny GJ; John TJ; Sridharan G; Gopal R
    J Med Virol; 2000 Oct; 62(2):293-7. PubMed ID: 11002261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modified vaccinia Ankara: potential as an alternative smallpox vaccine.
    McCurdy LH; Larkin BD; Martin JE; Graham BS
    Clin Infect Dis; 2004 Jun; 38(12):1749-53. PubMed ID: 15227622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transmission of vaccinia virus and rationale for measures for prevention.
    Lane JM; Fulginiti VA
    Clin Infect Dis; 2003 Jul; 37(2):281-4. PubMed ID: 12856220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immunity to vaccina virus of Japanese people of different age groups: serum antibody titre and local skin reaction at the site of vaccination.
    Kitaoka M; Nishimura C; Kimura M
    Prog Immunobiol Stand; 1970; 4():683-91. PubMed ID: 5482206
    [No Abstract]   [Full Text] [Related]  

  • 39. Picture of the month. Progressive vaccinia in an infant with severe combined immunodeficiency.
    Fulginiti VA; Feingold M
    Am J Dis Child; 1984 Mar; 138(3):321-2. PubMed ID: 6702780
    [No Abstract]   [Full Text] [Related]  

  • 40. Determination of immunity to vaccinia virus by using diluted inactivated vaccinia vaccine solution for skin testing.
    Somekh E; Smetana Z; Tanay A; Dalal I; Babai I; Mendelson E
    Vaccine; 2004 Dec; 23(3):321-4. PubMed ID: 15530675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.